The Department of Health and Social Care (DHSC) has today (28/05/2026) confirmed the following list of price concessions for May 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the [...]
The post May 2026 Price Concessions 4th Update appeared first on Community Pharmacy England.
The Department of Health and Social Care (DHSC) has today (22/05/2026) confirmed the following list of price concessions for May 2026: This includes an increased price for Pregabalin 100mg capsules Drug Pack size Price concession Acarbose 50mg tablets 90 £21.87 Apixaban 2.5mg tablets 60 £3.10 Apixaban 5mg tablets 56 £4.80 Aripiprazole 10mg tablets 28 £2.60 Aripiprazole [...]
The post May 2026 Price Concessions 3rd Update appeared first on Community Pharmacy England.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Trurapi® (insulin aspart) 100units/ml solution for injection 3ml pre-filled Solostar pens. MSN/2026/024 Tier 2 – Medium impact Date of issue: 18 May 2026 Trurapi® (insulin aspart) 100units/ml solution for injection 3ml pre-filled Solostar pens are in limited supply until late May [...]
The post Medicine supply Notification: Trurapi® (insulin aspart) 100units/ml solution for injection 3ml pre-filled Solostar pens appeared first on Community Pharmacy England.
The Department of Health and Social Care (DHSC) has today (15/05/2026) confirmed the following initial list of price concessions for May 2026: Drug Pack size Price concession Aspirin 75mg dispersible tablets 28 £2.83 Aspirin 75mg dispersible tablets 100 £10.10 Aspirin 75mg gastro-resistant tablets 28 £2.15 Benzydamine 0.15% oromucosal spray sugar free 30 £1.60 Captopril 25mg tablets [...]
The post May 2026 Price Concessions 1st Update appeared first on Community Pharmacy England.
MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) Drug alert number: EL(26)A/23 Date issued: 11 May 2026 Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets. DMRC reference number: DMRC- 39394163 Marketing Authorisation Holder: Milpharm Limited Medicine Details Product name: [...]
The post MHRA Class 4 Medicines Defect Notification: Loperamide hydrochloride 2 mg Orodispersible Tablets (Milpharm Ltd) appeared first on Community Pharmacy England.
Recent Comments